Article ; Online: Management of Allergic Diseases During COVID-19 Outbreak.
Current allergy and asthma reports
2021 Volume 21, Issue 2, Page(s) 8
Abstract: Purpose of review: The coronavirus disease 2019 (COVID-19) has challenged healthcare system capacities and safety for health care workers, reshaping doctor-patient interaction favoring e-Health or telemedicine. The pandemic situation may make difficult ... ...
Abstract | Purpose of review: The coronavirus disease 2019 (COVID-19) has challenged healthcare system capacities and safety for health care workers, reshaping doctor-patient interaction favoring e-Health or telemedicine. The pandemic situation may make difficult to prioritize patients with allergies diseases (AD), face-to-face evaluation, and moreover concern about the possible COVID-19 diagnosis, since COVID-19 shared many symptoms in common with AD. Being COVID-19 a novel disease, everyone is susceptible; there are some advances on vaccine and specific treatment. We evaluate existing literature on allergic diseases (AD): allergic rhinitis, asthma, food allergy, drug allergy, and skin allergy, and potential underlying mechanisms for any interrelationship between AD and COVID-19. Recent findings: There is inconclusive and controversial evidence of the association between AD and the risk of adverse clinical outcomes of COVID-19. AD patients should minimize hospital and face-to-face visits, and those who have used biologics and allergen immunotherapy should continue the treatment. It is essential to wear personal protective equipment for the protection of health care workers. Social distancing, rational use of facemasks, eye protection, and hand disinfection for health care workers and patients deserve further attention and promotion. Teleconsultation during COVID-19 times for AD patients is very encouraging and telemedicine platform can provide a reliable service in patient care. |
---|---|
MeSH term(s) | Asthma/immunology ; Asthma/therapy ; Biological Products ; COVID-19/prevention & control ; Dermatitis, Allergic Contact/immunology ; Dermatitis, Allergic Contact/therapy ; Dermatitis, Atopic/immunology ; Dermatitis, Atopic/therapy ; Desensitization, Immunologic ; Disease Management ; Disease Outbreaks ; Drug Hypersensitivity/immunology ; Drug Hypersensitivity/therapy ; Food Hypersensitivity/immunology ; Food Hypersensitivity/therapy ; Health Personnel ; Humans ; Infection Control/methods ; Pandemics/prevention & control ; Personal Protective Equipment ; Physical Distancing ; Rhinitis, Allergic/immunology ; Rhinitis, Allergic/therapy ; SARS-CoV-2 ; Telemedicine |
Chemical Substances | Biological Products |
Language | English |
Publishing date | 2021-02-09 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 2057370-4 |
ISSN | 1534-6315 ; 1529-7322 |
ISSN (online) | 1534-6315 |
ISSN | 1529-7322 |
DOI | 10.1007/s11882-021-00989-x |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5548: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.